Abstract:Objective: Post-traumatic osteoarthritis (OA) is associated with cartilage degradation resulting in changes in cell-matrix mediated signaling after injury. Matrix metalloproteinase-13 (MMP13) is a critical enzyme in this process, degrading the extracellular matrix and modifying receptors. One of the receptors altered by MMP13 is a transmembrane proteoglycan, Neuron Glial antigen 2 (NG2/CSPG4). In the temporomandibular joint (TMJ), NG2/CSPG4 is membrane bound and binds with type VI collagen. During OA, the NG2/CSPG4 intracellular domain is internalized into the cytosol. While NG2/CSPG4 is a known substrate for MMP13, there are important gaps in knowledge related to how MMP-13 modifies NG2/CSPG4 after injury. The hypothesis of this study is that MMP13 regulates NG2/CSPG4 interactions with the extracellular matrix, the internalization of the intracellular domain, and key cartilage signaling pathways during mechanical loading and OA progression. Methods: To characterize MMP13 and NG2/CSPG4 levels during the progression of TMJ OA, we used a surgical destabilization preclinical murine model (approved under UIC ACC #20-068) and compared them with clinical samples from human patients receiving total joint replacement for advanced stage TMJ OA (approved under UIC IRB #2017-0033). To mechanistically interrogate MMP-13-NG2/CSPG4, we cultured primary mandibular fibrochondrocytes and treated them with an MMP13 inhibitor (CAS 544678-85-5) at 15 nM for 24 hours or vehicle control. To evaluate matrix binding, we performed immunocytochemistry using an antibody against the NG2/CSPG4 ectodomain on decellularized coverslips. To mechanically load samples, cell-agarose-collagen scaffolds received a constrained static compression treatment for 2 hours at 2.5 N with and without the MMP13. Gene expression changes were quantified using RT-qPCR and protein changes were quantified with western blot. Data were evaluated using a one-way ANOVA. Results: Our results illustrate that MMP13 is present in preclinical and clinical samples a spatiotemporally consistent pattern with NG2/CSPG4 internalization. In vitro, the inhibition of MMP13 impairs the ability of the NG2/CSPG4 ectodomain to be retained in the extracellular matrix. Mechanical loading of the cells activates MMP13, leading to clearance of membrane associated NG2/CSPG4. Inhibition of MMP13 during mechanical loading promotes the accumulation of membrane associated NG2/CSPG4 and a decrease in internalized NG2/CSPG4 (n = 4; p < 0.05). MMP13 did not cause the complete proteolytic degradation of the ectodomain. This mechanically sensitive MMP-13-NG2/CSPG4 axis regulates the expression of key mineralization and OA genes including BMP2 and PTHrP (n = 4; p < 0.05). Conclusions: Together, these findings indicate that MMP13 mediated cleavage of NG2/CSPG4 potentiates the internalization of the intracellular domain and regulates genes implicated in the mineralization signaling axis during growth and degenerative diseases such as OA. Funding support from NIH/NIDCR 1R01DE029835-01. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Matrix metalloproteinase‐13 is fully activated by neutrophil elastase and inactivates its serpin inhibitor, alpha‐1 antitrypsin: Implications for osteoarthritis

Activation of the P38/CREB/MMP 13 Axis is Associated with Osteoarthritis

Neutrophil elastase and its inhibitors—overlooked players in osteoarthritis

The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover

Proteolysis of the Pericellular Matrix: Pinpointing the Role and Involvement of Matrix Metalloproteinases in Early Osteoarthritic Remodeling

Postnatal Expression in Hyaline Cartilage of Constitutively Active Human Collagenase-3 (Mmp-13) Induces Osteoarthritis in Mice

Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis

Angiotensin-converting Enzyme Defines Matrikine-Regulated Inflammation and Fibrosis

Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin

RANTES/CCL5 Induces Collagen Degradation by Activating MMP-1 and MMP-13 Expression in Human Rheumatoid Arthritis Synovial Fibroblasts

The Antagonistic Actions of Endogenous Interleukin-1β and 15-Deoxy-δ12,14-prostaglandin J2 Regulate the Temporal Synthesis of Matrix Metalloproteinase-9 in Sheared Chondrocytes

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis

The Involvement of Mutual Inhibition of ERK and mTOR in PLCγ1-Mediated MMP-13 Expression in Human Osteoarthritis Chondrocytes

The Effect of Protease Inhibitors on the Induction of Osteoarthritis-Related Biomarkers in Bovine Full-Depth Cartilage Explants

Advances in matrix metalloproteinase 13 in cartilage remodeling and arthritis

MMP-13 Regulates Matrix Binding and Internalization of NG2/CSGP4 in Mandibular Fibrochondrocytes

Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis

Proteoglycan and Collagen Degradation in Osteoarthritis

Matrix-degrading protease ADAMTS-5 cleaves inter-α-inhibitor and releases active heavy chain 2 in synovial fluids from arthritic patients

CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts

The Role of Cyclooxygenase-2, Interleukin-1β and Fibroblast Growth Factor-2 in the Activation of Matrix Metalloproteinase-1 in Sheared-Chondrocytes and Articular Cartilage